Document:

SECURITIES PURCHASE AGREEMENT

 

 

THIS SECURITIES PURCHASE AGREEMENT (the
“Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”)
whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and MBRG Investors LLC( “Purchaser”), a California
Limited Liability Company whose address is 9200 Sunset Boulevard, Suite 555 West Hollywood, CA .

 

WHEREAS:

 

The Purchaser desires to shares of common
stock in the Company (“Shares”) in accordance with the terms and conditions set forth herein.

 

The Company desires to issue and sell
Shares to the Purchaser in accordance with the terms and conditions set forth herein.

 

THEREFORE, IT IS AGREED AS FOLLOWS

 

 

1. Purchase Price

 

The purchase price per Share (“Purchase Price”),
payable in US Dollars, shall be $2.00 per Share.

 

 

2. Form of Payment

 

The Purchaser shall pay the Purchase
Price per Share multiplied by that number of Shares Purchased by wire transfer of immediately available funds to the Company

WIRE INSTRUCTIONS:

__________________

__________________

 

3. Issuance of Shares

 

5 business days subsequent to receipt
of payment of the Purchase Price the Company shall issue to the Purchaser that number of Shares purchased

4. Purchaser’s Representations and Warranties

 

	 	(a)	As of the date hereof, the Purchaser is purchasing the Shares for its own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the Securities Act of 1933, as amended (the “Act”). 

 

	 	(b)	The Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D promulgated under the Act

 

	 	(c)	The Purchaser and its advisors, if any, have been, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Shares which have been requested by the Purchaser or its advisors. Notwithstanding the foregoing, the Company has not disclosed to the Purchaser any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to such disclosure to the Purchaser.

 

    	 	1	 

     

    

 

	 	(d)	Purchaser has the requisite power and authority to enter into and perform its obligations under this Agreement without the consent, approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

	 	(e)	The execution, delivery and performance of this Agreement by Purchaser does not and shall not constitute Purchaser’s breach of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument to which the Purchaser is a party, or by which Purchaser is or may be bound.

 

5. Company’s representations and warranties

 

a) Company is a corporation duly organized, validly existing
and in good standing under the laws of the state its incorporation and has the requisite corporate power and authority to enter
into and perform its obligations under this Agreement without the consent, approval or authorization of, or obligation to notify,
any person, entity or governmental agency which consent has not been obtained.

(b) The execution, delivery and
performance of this Agreement by Company does not and shall not constitute Company’s breach of any statute or regulation
or ordinance of any governmental authority, and shall not conflict with or result in a breach of or default under any of the terms,
conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument to which the Company is a
party, or by which Company is or may be bound.

6. Restricted Securities Acknowledgement

 

Purchaser acknowledges that any
securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act of 1933 shall constitute
“restricted securities” as that term is defined in Rule 144 promulgated under the Act, and shall contain the following
restrictive legend:

“THESE SECURITIES HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF ANY STATE AND MAY NOT
BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH
LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED
TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS.”

8. Entire Agreement

This Agreement constitutes a final
written expression of all the terms of the Agreement between the parties regarding the subject matter hereof, are a complete and
exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings, and representations
between the parties.

9. Governing Law, Venue, Waiver of Jury Trial

All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the
internal laws of the State of California, without regard to the principles of conflicts of law thereof. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in California for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or inconvenient venue for such proceeding. If either party shall
commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding
shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.

    	 	2	 

     

    

 

IN WITNESS WHEREOF, the parties have hereunto executed
this Agreement on the 30th day of January 2018.

	Zander Therapeutics, Inc	 
	/s/ David Koos	 
	David Koos, CEO	 
	Date: 2/21/2018	 

 

	
        Purchaser

        MBRG Investors, LLC

        A California Limited Liability Company
	 
	/s/Joseph Mani	 
	Manager	 
	 	 
	 	 
	 	 
	Date: 2/20/2018	 
	Number of Shares Purchased: 100,000
	Total Purchase Price: $200,000Exhibit

Exhibit 10.7.2

FORM OF AMENDMENT TO EMPLOYMENT AGREEMENT

THIS AMENDMENT No. [•] (the “Amendment”), effective as ________ (“Amendment Effective Date”) to the Employment Agreement dated as of [ ][, as previously amended on [ ]] (the “Agreement”), by and among Aleris International, Inc., a Delaware corporation (together with its successors and assigns, the “Company”) and [•] (the “Executive”).

[WHEREAS, the Compensation Committee of the Company previously authorized and approved an amendment to the Agreement that changed how the Severance Payment was calculated and also changed when the Severance Payment is payable in the event that the Company terminates the Executive’s employment thereunder without Cause, or the Executive terminates his employment thereunder with Good Reason (collectively, the “Severance Changes”);] 1 

WHEREAS, the Compensation Committee of the Company intends that the Executive’s severance upon a termination without Cause or with Good Reason generally be equivalent to and paid in the same manner as the severance that would be received by the Executive upon a termination due to non-renewal of the term (after taking into account the requisite notice period) (the “Non-Renewal Severance Changes”);

WHEREAS, except as otherwise defined herein, capitalized terms used in this Amendment shall have the same definitions as set forth in the Agreement; and

WHEREAS, the Compensation Committee of the Company desires to approve the Non-Renewal Severance Changes by amending the Agreement as set forth herein.

NOW THEREFORE, for good and valuable consideration, the Executive and the Company agree as follows: 

		
	1.
	Amendment. 

APPLICABLE TO MESSRS. RYCHEL, KEOWN AND CLEGG, AND MS. POLMANTEER

[Section 5(d) is hereby deleted in its entirety and replaced as follows: 

Non-Renewal by the Company. If the Company elects, pursuant to the first sentence of Section 3 of this Agreement, not to extend the Employment Period and the Executive’s employment hereunder ends on the Scheduled Termination Date, then subject to Section 5(f) hereof, the Executive shall be entitled to receive: (i) the Accrued Benefits, to be paid/provided in accordance with the terms of the applicable plan, program, agreement or benefit or as required by law; (ii) a cash payment (the “Non-Renewal Payment”) equal to one (1) times the sum of (x) the annual Base Salary as of the Scheduled Termination Date (disregarding, for this purpose, any reduction in the Base Salary that occurred after the Amendment Effective Date) and (y) the annual Target Bonus as of the Scheduled Termination Date (disregarding, for the purpose of 

1NTD: Not applicable for Keown.

determining the Target Bonus, any reduction in Base Salary that occurred after the Amendment Effective Date), to be paid in substantially equal installments consistent with the Company’s payroll practices over the twelve (12) months following the Scheduled Termination Date, with any installment due to be paid prior to the date that the condition described in Section 5(f)(i) has been satisfied being accumulated and paid within fifteen (15) days after such condition is satisfied, and with the last installment being paid on or before the twelve (12) month anniversary of the Scheduled Termination Date, provided, however, that if the Company’s payroll practices change after the Executive has begun to receive payments under this Section 5(d), the Executive shall continue to receive payments in accordance with the schedule in effect at the time that the Executive began to receive payments under this Section 5(d); and (iii) Welfare Benefits Continuation for the twelve (12) month period following the Scheduled Date of Termination; provided, further, however, notwithstanding the foregoing, if termination of employment is in anticipation of or within twelve (12) months following a Change of Control (as defined in the LTIP, as amended), the Non-Renewal Payment will be paid in a cash lump sum within thirty (30) days following the Date of Termination, to the extent permissible under the rules regarding a “short-term deferral” within the meaning of Treasury Regulations Section 1.409A-1(b)(4) of the Code and “separation pay plans” within the meaning of Treasury Regulations Section 1.409A-1(b)(9) of the Code, or as otherwise would not subject the Executive to taxes under Section 409A of the Code. For purposes of the foregoing, a termination of employment will be deemed to be “in anticipation of” a Change of Control if such termination is for the principal purpose of avoiding or evading the Company’s or Parent’s compensation obligations that would arise upon a termination following a Change of Control.] 2 

APPLICABLE TO MR. STACK

[Section 5(d) is hereby deleted in its entirety and replaced as follows: 
    
Non-Renewal by the Company. If the Company elects, pursuant to the first sentence of Section 3 of this Agreement, not to extend the Employment Period and the Executive’s employment hereunder ends on the Scheduled Termination Date, then subject to Section 5(f) hereof, the Executive shall be entitled to receive: (i) the Accrued Benefits, to be paid/provided in accordance with the terms of the applicable plan, program, agreement or benefit or as required by law; (ii) the Prior Year Bonus (to the extent not yet fully paid), to be paid in cash only when annual bonus amounts are paid to other senior executives of the Company generally but in no event later than two and one-half (2-1/2) months following the calendar year with respect to which such Prior Year Bonus was earned; and (iii) a cash payment (the “Non-Renewal Payment”) equal to three (3) times the sum of (x) the annual Base Salary as of the Scheduled Termination Date (disregarding, for this purpose, any reduction in the Base Salary that occurred after the Amendment Effective Date) and (y) the annual Target Bonus as of the Scheduled Termination Date (disregarding, for the purpose of determining the Target Bonus, any reduction in Base Salary that occurred after the

2NTD: Applicable to all U.S. NEOs other than Stack.

Amendment Effective Date), to be paid in substantially equal installments consistent with the Company’s payroll practices over the twenty-four (24) months following the Scheduled Termination Date, with any installment due to be paid prior to the date that the condition described in Section 5(f)(i) has been satisfied being accumulated and paid within fifteen (15) days after such condition is satisfied, and with the last installment being paid on or before the twenty-four (24) month anniversary of the Scheduled Termination Date, provided, however, that if the Company’s payroll practices change after the Executive has begun to receive payments under this Section 5(d), the Executive shall continue to receive payments in accordance with the schedule in effect at the time that the Executive began to receive payments under this Section 5(d); and (iv) Welfare Benefits Continuation for the twenty-four (24) month period following the Scheduled Date of Termination, in accordance with Section 5(a)(i)(D); provided, further, however, notwithstanding the foregoing, if termination of employment is in anticipation of or within twelve (12) months following a Change of Control (as defined in the LTIP as modified by Section 2(c)(iv) hereof)), the Non-Renewal Payment will be paid in a cash lump sum within thirty (30) days following the Date of Termination, to the extent permissible under the rules regarding a “short-term deferral” within the meaning of Treasury Regulations Section 1.409A-1(b)(4) of the Code and “separation pay plans” within the meaning of Treasury Regulations Section 1.409A-1(b)(9) of the Code, or as otherwise would not subject the Executive to taxes under Section 409A of the Code. For purposes of the foregoing, a termination of employment will be deemed to be “in anticipation of” a Change of Control if such termination is for the principal purpose of avoiding or evading the Company’s or Parent’s compensation obligations that would arise upon a termination following a Change of Control.] 3 

		
	1.
	Other.     Except as amended hereby, the Agreement shall remain in full force and effect. 

[Signature Page Follows]

3NTD: Applicable to Stack only.

IN WITNESS WHEREOF, the Parties have executed this Amendment as of the date first written above. 

EXECUTIVE

______________________________
[Executive]

ALERIS INTERNATIONAL, INC.

                            

By:______________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]